Mannucci L, Gerometta P S, Mussoni L, Antona C, Parolari A, Salvi L, Biglioli P, Tremoli E
Institute of Pharmacological Sciences, University of Milan, Italy.
Thromb Haemost. 1995 Mar;73(3):356-61.
It is already known that activation of the coagulation and fibrinolytic system occurs in patients undergoing cardiopulmonary bypass (CPB). We have thus studied twenty patients (10 treated with aprotinin during CPB and 10 untreated) both during the intraoperative period and during thirty days follow up. In untreated patients D-dimer levels increased 4-fold during CPB and the levels were above baseline for the whole follow up (p < 0.0001). D-dimer levels were reduced in aprotinin treated patients in comparison to untreated patients (p = 0.0172); levels then gradually increased to the values of the untreated patients over the following 24 h later and remained higher during the thirty day follow up. The behavior of haemostatic variables in the 24 h after CPB did not vary between untreated and aprotinin treated patients. In particular, five minutes after protamine sulphate administration, levels of F1 + 2 and TAT rose significantly (p = 0.0054, p = 0.0022 respectively), whereas fibrinogen significantly decreased (p < 0.0001) and PAI-1 antigen levels were reduced. Two days after CPB the concentrations of F1 + 2 and TAT lowered, whereas fibrinogen and PAI-1 antigen levels increased. On the 5th, 8th and 30th days after CPB, F1 + 2 and TAT levels remained higher than those reported at baseline in both groups of patients, whereas fibrinogen levels increased over basal levels in aprotinin treated patients only. Thus, in addition to the activation of the coagulation and fibrinolytic system occurring during the intraoperative period, in patients undergoing CPB, there are alterations of haemostatic variables up to thirty days from surgery.
已知在接受体外循环(CPB)的患者中会发生凝血和纤维蛋白溶解系统的激活。因此,我们研究了20例患者(10例在CPB期间接受抑肽酶治疗,10例未接受治疗),观察了术中及术后30天的情况。在未治疗的患者中,CPB期间D - 二聚体水平增加了4倍,并且在整个随访期间该水平均高于基线水平(p < 0.0001)。与未治疗的患者相比,抑肽酶治疗的患者D - 二聚体水平降低(p = 0.0172);随后在接下来的24小时内逐渐升高至未治疗患者的值,并在30天的随访期间保持较高水平。CPB后24小时内,未治疗和抑肽酶治疗的患者止血变量的变化情况没有差异。具体而言,在注射硫酸鱼精蛋白5分钟后,F1 + 2和TAT水平显著升高(分别为p = 0.0054,p = 0.0022),而纤维蛋白原显著降低(p < 0.0001),PAI - 1抗原水平降低。CPB后两天,F1 + 2和TAT的浓度降低,而纤维蛋白原和PAI - 1抗原水平升高。在CPB后的第5天、第8天和第30天,两组患者的F1 + 2和TAT水平均高于基线水平,而仅在抑肽酶治疗的患者中纤维蛋白原水平高于基础水平。因此,除了术中发生的凝血和纤维蛋白溶解系统激活外,接受CPB的患者在术后30天内止血变量也会发生改变。